[go: up one dir, main page]

EE05333B1 - Makroliidhendite konjugaadid p?letikuvastaste henditega ja nende kasutamine - Google Patents

Makroliidhendite konjugaadid p?letikuvastaste henditega ja nende kasutamine

Info

Publication number
EE05333B1
EE05333B1 EEP200300293A EEP200300293A EE05333B1 EE 05333 B1 EE05333 B1 EE 05333B1 EE P200300293 A EEP200300293 A EE P200300293A EE P200300293 A EEP200300293 A EE P200300293A EE 05333 B1 EE05333 B1 EE 05333B1
Authority
EE
Estonia
Prior art keywords
conjugates
inflammatory agents
macrolide compounds
macrolide
compounds
Prior art date
Application number
EEP200300293A
Other languages
English (en)
Estonian (et)
Inventor
Mercep Mladen
Mesic Milan
Tomaskovic Linda
Komac Marijana
Hrvacic Boska
Markovic Stribor
Original Assignee
Pliva D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva D.D. filed Critical Pliva D.D.
Publication of EE200300293A publication Critical patent/EE200300293A/xx
Publication of EE05333B1 publication Critical patent/EE05333B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200300293A 2001-01-09 2002-01-03 Makroliidhendite konjugaadid p?letikuvastaste henditega ja nende kasutamine EE05333B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20010018A HRP20010018A2 (en) 2001-01-09 2001-01-09 Novel anti-inflammatory compounds
PCT/HR2002/000001 WO2002055531A1 (en) 2001-01-09 2002-01-03 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy

Publications (2)

Publication Number Publication Date
EE200300293A EE200300293A (et) 2003-10-15
EE05333B1 true EE05333B1 (et) 2010-08-16

Family

ID=10947235

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300293A EE05333B1 (et) 2001-01-09 2002-01-03 Makroliidhendite konjugaadid p?letikuvastaste henditega ja nende kasutamine

Country Status (23)

Country Link
US (2) US7446097B2 (xx)
EP (1) EP1351973B1 (xx)
JP (1) JP4474101B2 (xx)
CN (1) CN1269836C (xx)
AR (1) AR035727A1 (xx)
AT (1) ATE462713T1 (xx)
BG (1) BG108073A (xx)
BR (1) BR0206347A (xx)
CA (1) CA2434009C (xx)
CZ (1) CZ20031825A3 (xx)
DE (1) DE60235794D1 (xx)
EA (1) EA007061B1 (xx)
EE (1) EE05333B1 (xx)
ES (1) ES2342364T3 (xx)
GE (1) GEP20053607B (xx)
HR (1) HRP20010018A2 (xx)
HU (1) HUP0500180A3 (xx)
IL (1) IL156673A0 (xx)
PL (1) PL207636B1 (xx)
RS (1) RS51308B (xx)
SK (1) SK9792003A3 (xx)
UA (1) UA77166C2 (xx)
WO (1) WO2002055531A1 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002109169A (ja) * 2000-09-29 2002-04-12 Hitachi Ltd 作業支援方法並びにシステム及び作業支援方法を記録した記録媒体
WO2003070173A2 (en) 2002-02-15 2003-08-28 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
HRP20040850A2 (en) * 2002-02-15 2005-08-31 Synovo Gmbh Conjugates of biologically active compounds, methods for their preparation and use formulation and pharmaceutical applications thereof
WO2003070254A1 (en) 2002-02-15 2003-08-28 Sympore Gmbh Antibiotic conjugates
NZ537717A (en) 2002-07-08 2006-04-28 Pliva Istrazivacki Inst D New compounds, compositions and methods for treatment of inflammatory diseases and conditions
PL374646A1 (en) * 2002-07-08 2005-10-31 Pliva-Istrazivacki Institutt D.O.O. Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
DE60327341D1 (de) * 2002-07-08 2009-06-04 Glaxosmithkline Zagreb Hybridmoleküle von makroliden mit steroidalen/nicht-steroidalen antientzündlich aktiven molekülen
HRP20030324A2 (en) * 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
WO2005030227A1 (en) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
JP4737495B2 (ja) * 2004-01-14 2011-08-03 塩野義製薬株式会社 エリスロマイシン誘導体
US20060183696A1 (en) * 2004-08-12 2006-08-17 Pliva-Istrazivacki Institut D.O.O. Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract
JP2008509899A (ja) * 2004-08-12 2008-04-03 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 胃腸管の炎症性疾患治療用の細胞特異的コンジュゲートの使用
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
WO2006046123A2 (en) 2004-10-27 2006-05-04 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Conjugates with anti-inflammatory activity
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
US20080249034A1 (en) * 2005-03-21 2008-10-09 Zambon S.P.A. Use of Macrolides for Treating Intestinal Inflammation
WO2011116312A1 (en) * 2010-03-19 2011-09-22 Catabasis Pharmaceuticals, Inc. Fatty acid macrolide derivatives and their uses
JP2016505038A (ja) * 2013-01-23 2016-02-18 スファエラ ファーマ プライベート リミテッド ミトコンドリア生合成ならびにミトコンドリア機能不全または欠乏に関連する疾患において使用するための１１β−ヒドロキシステロイドの新規の化合物
CN106714770B (zh) 2014-07-23 2024-04-19 斯法尔制药私人有限公司 羟基类固醇化合物、其中间体、制备方法、组合物及其用途
GB201520419D0 (en) 2015-11-19 2016-01-06 Epi Endo Pharmaceuticals Ehf Compounds
WO2023248010A2 (en) * 2022-06-23 2023-12-28 Synovo Gmbh Targeted modulators of jak3 for treatment of inflammatory and autoimmune diseases

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710495A (en) 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
EP0283055B1 (en) 1987-09-03 1990-08-29 SOUR PLIVA farmaceutska, Kemijska prehrambena i kozmeticka industrija, n.sol.o. 10-dihydro-10-deoxo-11-azaerythronolide-a-compounds, methods and intermediates for the manufacture thereof and their use in pharmaceuticals and in the manufacture thereof
JPH01163124A (ja) 1987-12-21 1989-06-27 Yamayuu Seikatsushiya:Kk 外用鎮痛消炎消腫消膿剤
SE9100342D0 (sv) 1991-02-04 1991-02-04 Astra Ab Novel steroid esters
SE9100341D0 (sv) 1991-02-04 1991-02-04 Astra Ab Novel steroids
GB9225923D0 (en) 1992-12-11 1993-02-03 Rhone Poulenc Rorer Ltd New compositions of matter
PL309402A1 (en) 1992-12-24 1995-10-02 Rhone Poulenc Rorer Ltd Novel steroides
CA2196879A1 (en) 1994-08-12 1996-02-22 Akihiko Hoshino Interleukin-5 production inhibitor
CA2196878A1 (en) 1994-08-12 1996-02-22 Akihiko Hoshino Interleukin-5 production inhibitor
DE19542949A1 (de) 1995-11-17 1997-07-17 Hilti Ag Bolzen zum Eintreiben in harte Aufnahmewerkstoffe
US5928868A (en) * 1996-04-26 1999-07-27 Massachusetts Institute Of Technology Three hybrid screening assay
FR2776927B1 (fr) 1998-04-07 2002-07-05 Univ Paris Curie Compositions pour la vectorisation de molecules
AU4549999A (en) * 1998-06-08 1999-12-30 Advanced Medicine, Inc. Novel polyene macrolide compounds and uses
AU4543899A (en) * 1998-06-08 1999-12-30 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein
IT1306205B1 (it) 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
HRP20040850A2 (en) 2002-02-15 2005-08-31 Synovo Gmbh Conjugates of biologically active compounds, methods for their preparation and use formulation and pharmaceutical applications thereof

Also Published As

Publication number Publication date
CA2434009C (en) 2009-09-29
EP1351973A1 (en) 2003-10-15
IL156673A0 (en) 2004-01-04
US20090105163A1 (en) 2009-04-23
CN1269836C (zh) 2006-08-16
HUP0500180A2 (en) 2006-09-28
RS51308B (sr) 2010-12-31
YU55203A (sh) 2006-03-03
EA007061B1 (ru) 2006-06-30
EP1351973B1 (en) 2010-03-31
CN1491230A (zh) 2004-04-21
WO2002055531A1 (en) 2002-07-18
JP4474101B2 (ja) 2010-06-02
BR0206347A (pt) 2004-02-10
GEP20053607B (en) 2005-09-12
BG108073A (bg) 2005-05-31
US7928078B2 (en) 2011-04-19
AR035727A1 (es) 2004-07-07
EA200300781A1 (ru) 2003-12-25
ES2342364T3 (es) 2010-07-06
US7446097B2 (en) 2008-11-04
DE60235794D1 (de) 2010-05-12
CA2434009A1 (en) 2002-07-18
PL207636B1 (pl) 2011-01-31
SK9792003A3 (en) 2004-01-08
HRP20010018A2 (en) 2002-12-31
HUP0500180A3 (en) 2009-12-28
US20040198677A1 (en) 2004-10-07
HK1065320A1 (en) 2005-02-18
JP2004518670A (ja) 2004-06-24
EE200300293A (et) 2003-10-15
ATE462713T1 (de) 2010-04-15
PL363478A1 (en) 2004-11-15
UA77166C2 (en) 2006-11-15
CZ20031825A3 (cs) 2003-11-12

Similar Documents

Publication Publication Date Title
EE05333B1 (et) Makroliidhendite konjugaadid p?letikuvastaste henditega ja nende kasutamine
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
ID30590A (id) Celana sekali pakai jenis-celana pendek
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
EE200200715A (et) Asendatud kinasoliini derivaadid ja nende kasutamine inhibiitoritena
NO20031869D0 (no) Antiinflammatoriske midler
AR027938A1 (es) Compuestos uracilo y utilizacion de los mismos
DE60208351D1 (de) Glukopyranosyloxybenzylbenzolderivate und deren medizinische verwendung
DE60230591D1 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
DE60237580D1 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
EE05169B1 (et) Asendatud oksasolidinoonid ja nende kasutamine
AR028567A1 (es) Nuevos derivados de fenil-propargileter
FR2803516B1 (fr) Formulation injectable de fulvestrant
EP1298180A4 (en) HYDROPHOBIC AND LIPOPHOBE COMPOSITION
NO20031407D0 (no) Glukopyranosyloksybenzylbenzen-derivater og medisinske sammensetninger inneholdende det samme
AR028596A1 (es) Nuevos derivados de fenilglicina
EE05020B1 (et) Glburiidi ravimkoostis
BRPI0208558A2 (pt) preparado de combinação de estrogênio-gestagênio e uso
ID30187A (id) Dongkrak jenis pantagraf
FI20011671L (fi) Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
EE05537B1 (et) Neublastiini polmeerkonjugaadid ja meetodid nende kasutamiseks
DE60109003D1 (de) Viskose und Amin-gehärtete Dübelmasse
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
HB1A Correction of owner name or address
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20120103